MAR 30, 2021 11:00 AM PDT

Getting to know your BD Veritor™ System for Rapid Detection of SARS-CoV-2

Sponsored by: BD
Speakers
  • IDS Business Integrator, GPOs
    Biography
      David has a history with Point of Care testing that spans over 15 years. He also has a 25 year clinical background with a focus on microbiology and Public Health
    • BD Product Manager, Point of Care
      Biography
        Chris is a former biomedical engineer turned marketer with 6 years of experience delivering innovative solutions that help improve people's lives.

      Abstract
      Date:  March 30, 2021
      Time: 11:00am (PDT),  2:00pm (EDT)
       
      As the world continues to have a need for COVID-19 testing, BD offers a reliable rapid antigen COVID-19 testing solution through the BD Veritor™ System for Rapid Detection of SARS-CoV-2*. This presentation will provide an overview of the role of antigen testing, review what the BD Veritor™ System for Rapid Detection of SARS-CoV-2, demonstration how to use the device and review the available educational resources for you and your staff.
       
      Learning Objectives
      • To review and understand the role of rapid antigen testing for SARS-CoV-2
      • To learn about the BD Veritor™ System for Rapid Detection of SARS-CoV-2
      • To learn how to perform a COVID-19 test using the BD Veritor™ System for Rapid Detection of SARS-CoV-2
       
      *This product has not been FDA cleared or approved; but has been authorized by FDA under an Emergency Use Authorization for use by authorized laboratories. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
       
      Webinars will be available for unlimited on-demand viewing after live event.
       

      Show Resources
      You May Also Like
      FEB 24, 2021 10:00 AM PST
      C.E. CREDITS
      FEB 24, 2021 10:00 AM PST
      DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
      MAY 11, 2021 10:00 AM PDT
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      DEC 03, 2020 4:30 PM PST
      C.E. CREDITS
      DEC 03, 2020 4:30 PM PST
      This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      MAR 16, 2021 10:00 AM PDT
      C.E. CREDITS
      MAR 16, 2021 10:00 AM PDT
      Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
      APR 20, 2021 11:00 AM PDT
      C.E. CREDITS
      APR 20, 2021 11:00 AM PDT
      Date: April 20, 2021 Time: 11:00am (PST), 2:00pm (EST) Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information...
      Loading Comments...
      Show Resources
      Attendees
      • See more